Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7517903 Cytotoxic compounds and conjugates

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
May 19, 2005
Date of Patent
April 14, 2009
Patent Application Number
11134685
Patent Citations Received
‌
US Patent 12129309 Heterodimeric antibodies that bind CD3 and CD38
0
‌
US Patent 12091693 PSMA binding ligand-linker conjugates and methods for using
0
‌
US Patent 12102689 Anti-CD22 antibody-maytansine conjugates and methods of use thereof
0
‌
US Patent 11673972 Heterodimeric antibodies that bind CD3 and tumor antigens
0
‌
US Patent 11788066 Antibody conjugates and methods of making and using the same
‌
US Patent 11840579 Bispecific antibodies that bind to CD38 and CD3
0
‌
US Patent 11859012 Heterodimeric antibodies that bind CD3 and GPC3
0
‌
US Patent 11919956 Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3
0
‌
US Patent 11931430 Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer
0
‌
US Patent 11945880 Heterodimeric antibodies that bind CD3 and tumor antigens
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7517903
Patent Primary Examiner
‌
Kamal A Saeed

Find more entities like US Patent 7517903 Cytotoxic compounds and conjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.